Where We’re Going: The Next Wave of Antiretroviral Innovations

In this second of 3 episodes, global HIV experts and advocates discuss how HIV care can better meet the diverse needs of people living with HIV as new treatment strategies emerge and continue to evolve, including:

• How the emergence of long-acting injectable HIV treatment has been a game-changer for many people living with HIV
• Emerging strategies that are expanding the application of long-acting ART to address unmet treatment needs
• Potential for future innovations in ART that are hoped will further address unmet needs and preferences of people living with HIV

Faculty: 

Ann Avery, MD
Professor of Medicine
Case Western Reserve University
Division of Infectious Diseases
MetroHealth Medical Center
Cleveland, Ohio

Jennifer Blanchette, PhD
Independent Contractor
Clinical Care Options
Colorado, United States

Isolde Butler, MD, MPH
Chief Medical Officer
CrescentCare
New Orleans, Louisiana

Monica Gandhi, MD, MPH
Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Director, Center for AIDS Research (CFAR)
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco (UCSF)
San Francisco, California

Marissa Gonzalez
Chair 
Community Advisory Board 
The Well Project

Angelina Namiba 
Founder Member
4M Network of Mentor Mothers
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
Blizard Institute
Barts Health NHS Trust
London, United Kingdom

Link to full program:
https://bit.ly/3QFwv7n

Links to programs discussed in the episode:
www.4mmm.org